Tag Archives: AI drug discovery

Recursion Pharmaceuticals director sells over $78k in company stock, sparking intrigue and raising questions about the company’s future trajectory. This move comes amidst a period of heightened scrutiny for the pharmaceutical industry, as investors grapple with the complexities of innovation and market volatility. The director’s decision to sell such a …

Read More »